Highlight of the month.

Who Gets Studied: Underrepresentation in Cancer Research

In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe and Dr. Irene Paassen explore who gets left out of cancer research, from rare childhood cancers diagnosed in...

Meet PAICON at the ESMO AI & Digital Oncology Congress 2026

PAICON will exhibit at the ESMO AI & Digital Oncology Congress 2026 in Berlin from 16 to 18 November, at booth 24. Join a live PaiX...

Why health AI needs representative data, and why it is so hard to access

Around 84% of the global population is underrepresented in the data health AI learns from. We look at why representative data matters, how the EU AI...

BiotechX Europe and the case for representative data

We exhibited at BiotechX Europe in Basel with live demos of PaiX Navigator. Across three days of sessions and booth conversations, one topic kept coming back:...

Ground Truth: Can an agentic platform reproduce published cancer research?

Can an agentic AI platform be trusted to answer questions over patient-level data? We asked PaiX Navigator to reproduce findings from six published TCGA studies. Of...

Momentum, but for whom? Reflections from the Arvato Systems Life Science Symposium

At Arvato Systems’ 11th Life Science Symposium in Berlin, one question kept coming back: if AI in healthcare is gaining momentum, whose data is it built...

Uncertainty-aware triage of microsatellite instability status in colorectal cancer from H&E-stained whole-slide images

Aswolinskiy W, Motiwala M, Paulikat M, Nelius N, Ahadova A, Adam P, Schmidt D, Kloor M, Aichmüller C

A model that reads microsatellite instability status straight from routine H&E slides, and abstains when it is not sure. Trained on 1,242 cases and tested on 1,094 from five independent cohorts, it...

From Proof of Concept to Product: What We Learned Building PaiX Navigator

Almost every AI project in life sciences can produce a convincing demo. Far fewer become something a pharma team, a diagnostics developer or a regulator would...

PAICON Strengthens its India Ties Onsite

Our Co-Founder and CEO and our Commercial & Partnerships Lead traveled to India to strengthen existing partnerships and explore new collaborations.

Most of the World is Still Missing From the Data Shaping Health AI

A new discussion paper outlines the representation gap in health AI, tracing how it compounds across the entire policy cycle. See how PaiX Navigator is built...

Behind PaiX Navigator: The Journey From Fragmented Data to Global Insight

In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe and Dr. John KL Wong argue that harmonization is the real bottleneck in global health, and explain how...

Health AI Bias Starts with Data: Our CEO on AI InterConnect Podcast

Our CEO Dr. Manasi Aichmüller-Ratnaparkhe joined the AI InterConnect Podcast, hosted by Laurent Cochet, to talk about the data gap behind AI bias in healthcare and...

The Case for Interpretable AI in Medicine

LLMs are reshaping clinical decision support, but their outputs are hard to explain. In this blog, our Platform & DevOps Engineer Dr. med. Simon Kalteis makes...

PAICON Expands On-the-Ground Presence in India

Our CEO & Co-Founder Dr. Manasi Aichmüller-Ratnaparkhe and Commercial & Partnerships Lead Dr. Jubin Shah travel to India in August to deepen data partnerships, advancing the...

Explainable AI in Healthcare: Why Clinician Trust Still Depends on Data

Explainable AI in healthcare is under scrutiny. New clinician trust research and a recent health equity report both point to the same fix for black box...

remaining84: The Book That Names Medicine's Missing 84%

Dr. Manasi Aichmüller-Ratnaparkhe, CEO and Co-Founder of PAICON, has published her first book: remaining84: The Missing Foundation of Personalized Medicine. It is now available on Amazon....

The Invisible Patient: Who Precision Medicine Actually Serves

In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe and Dr. Vinod Gauba argues that representation bias extends far beyond ethnicity and that fixing it requires rebuilding...

Precision Oncology's Next Challenge in India: Identifying HER2-Low Patients at Scale

As drugs like Enhertu expand into HER2-low breast cancer, India's fragmented pathology infrastructure makes consistent biomarker identification a structural bottleneck, not a clinical one. This piece...

PAICON at HLTH Europe: Data Equity Takes Center Stage in Amsterdam

At HLTH Europe, our CEO Dr. Manasi Aichmüller-Ratnaparkhe joined a data equity panel to argue that the barrier to closing the global health data gap has...

Why Medical AI Doesn't Travel: Building Data Systems That Cross Borders

Medical AI models often lose accuracy at new hospitals not because the model is flawed, but because the underlying data system wasn't built to travel. This...

PAICON at bio:cap Europe: Bringing PaiX Navigator to Berlin

PAICON brought PaiX Navigator to bio:cap Europe in Berlin, where CEO Dr. Manasi Aichmüller-Ratnaparkhe took the Startup Stage to introduce the company's mission to founders, investors,...

The Translational Gap in Medicine: Why Discoveries Don't Reach Patients

In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe and Dr. Christian Tidona explore why groundbreaking biomedical discoveries so rarely make it to patients from misaligned startup...

PAICON is Taking the Stage at HLTH Europe

PAICON is taking the stage at HLTH Europe 2026 in Amsterdam, June 15–18. Our CEO Dr. Manasi Aichmueller-Ratnaparkhe joins the AI Stage on June 17 for...

The Clock is Running Before the Science Even Starts

Before the science can start, the clock is already running. This piece examines why data access is the most cited barrier in clinical research, and what...

Meet PAICON at bio:cap Europe 2026 in Berlin

PAICON is heading to bio:cap Europe 2026 in Berlin. Book a meeting with our team for an exclusive PaiX Navigator Demo.

Designing Globally Scalable Oncology Data Systems

As the global cancer burden approaches 35 million new cases by 2050, building AI systems that reliably work across diverse populations, institutions, and jurisdictions has never...

Predicting Biochemical Recurrence from Prostatectomy Slides - the LEOPARD Challenge

Faryna K, Grisi C, Uysal N, Pinckaers H, Bogaerts J, Kammerer-Jacquet SF, Allaume P, Agosti V, de Oliveira Salles PG, Tolkach Y, Buettner R, Semko S, Pikul M, Heidenreich A, Kowalewski A, Tessier L, Meeuwsen F, van Ipenburg J, Nicke T, Lotz J, Schaefer JR, McNeil M, Martel AL, Aswolinskiy W, Aichmüller C, Fang Z, Jiang S, Yan X, Ouyang Q, Zhang Y, Achanta S, Chattopadhyay N, Mohammad RF, Vartak A, Singhal N, Zhang L, Kutzer A, Ghaffari Laleh N, Kather JN, Bui DC, Nguyen AT, Park S, Kwak JT, You S, Adap S, Thakur S, Baheti B, Bakas S, Munari E, van der Laak J, Litjens G

An international benchmark of AI models predicting time to biochemical recurrence straight from H&E prostatectomy slides, on 2,181 cases from four countries. The top ensemble matched histopathological grading, and adding it to...

Rare Diseases, Missing Data, and the Limits of Modern Medicine

In this episode of ByteSight, Dr. Manasi A-Ratnaparkhe and Faizan S. Mohammad, founder of Leg&airy, challenge the label rare disease, exploring why 300 million patients remain...

PAICON Returns to DMEA as Nova Award Recipients

PAICON returned to DMEA 2026 as Nova Award recipients, showing a live demo of PaiX Navigator and announcing the book Remaining84, making the case that representative...

When AI Models Break: How Data Lineage Tells You Why

When diagnostic AI models fail, the cause is rarely the model itself. Learn how data lineage traces failures back to their root cause in the data...

Fast organ-of-origin classification for digital pathology quality control

Aswolinskiy W, Wong JKL, Zapukhlyak M, Kindruk Y, Pavlova M, Laskorunskyi R, Paulikat M, Aichmüller C

A model that reads the organ of origin from a single low-resolution thumbnail in under a second, so mislabelled slides are caught early instead of after they reach a diagnostic pipeline.

Rare Disease is Where the Data Gap Is Most Visible

95% of rare diseases have no approved treatment. Discover why the rare disease field is the sharpest example of the global medical data gap, and what...

Meet Us at DMEA 2026: Showcasing the Future of Global Health Data

At DMEA 2026 in Berlin, as a DMEA NOVA Award Winner 2025, we showcase PaiX Navigator, our global health data infrastructure driving diverse, clinically validated AI...

Harmonization Over Volume: Why More Data Isn't Better

Why more data doesn’t always improve healthcare AI. Learn how data harmonization enhances generalization, reduces bias, and enables reliable clinical AI performance.

PAICON at Health.Tech Global Summit Basel: Advancing Inclusive, Data-Driven AI in Healthcare

At Health.Tech Global Summit Basel, PAICON highlights the role of global, high-quality data and harmonization in building inclusive, trustworthy healthcare AI systems.

Why Medical AI Fails in the Real-World: From High Accuracy to Poor Generalization

Why medical AI models fail in real-world clinical settings despite high accuracy. Explore the generalization gap, data variability, and how to build robust healthcare AI systems....

AI as Data, Expertise as Insight in Life Sciences

In this ByteSight episode, Dr. Grant Coren explores why AI in life sciences depends on diverse data, human expertise, and governance—challenging the hype around automation in...

Meet PAICON in Basel: Panel on  Real-World Healthcare Innovation

Our co-founder & CEO will speak at Superlab Suisse in Basel on multimodal clinical data and AI-driven innovation, while the PAICON team also engages with global...

Insights from WHX Dubai: Scaling HealthTech with Purpose

At WHX Dubai, our CEO explored why scaling a HealthTech startup isn’t just about growth—it’s about building responsible AI infrastructure, globally representative data foundations, and long-term...

External Validation in Cancer AI: Why Generalization is the Real Benchmark

External validation is emerging as the defining benchmark in cancer AI, as digital pathology models must demonstrate robust cross-institutional generalization beyond high internal AUC scores.

Diversity over scale: Whole-slide image variety enables H&E foundation model training with fewer patches

Bosch C, Wong JKL, Paulikat M, Zapukhlyak M, Arora B, Aichmüller-Ratnaparkhe M, Baumann J, Karn S, Kamble R, Karnik S, Khedkar B, Chhut SV, Aswolinskiy W, Aichmüller C

Athena, our H&E foundation model, was trained on 115 million patches from 282k slides, several times fewer than comparable models, and still approaches the state of the art. Diversity across slides, not...

Metadata is the Missing Infrastructure Layer in Cancer AI

Cancer AI doesn’t fail because of weak algorithms, but it fails because of missing metadata, the invisible infrastructure layer that determines whether models generalize, meet EU...

PaiX Net: A Next-Generation Second-Opinion Platform for Pathology

Baumann J, Kanani B, Tamboli S, Kucherenko Y, Fritz P, Aswolinskiy W, Bosch C, Paulikat M, Wong JKL, Arora B, Zapukhlyak M, Eickmeyer J, Pavlova M, Laskorunskyi R, Kindruk Y, Kalteis S, Tamang N, Aichmüller-Ratnaparkhe M, Yazli G, Uluc G, Adam P, Quick D, Aichmüller C

A structured, AI-augmented second-opinion platform that keeps the diagnostic decision with the expert. Standardised case templates, moderated discussion and AI assistance in one browser-based, GDPR-compliant system.

From Data Chaos to Clinical Clarity: How Pharma Turns Messy Clinical & Omics Data into Decisions

In this ByteSight episode, Dr. Paul Agapow explores why real clinical AI impact depends not only on powerful models, but on trustworthy data, validation, and adoption...

PAICON’s CEO and Co-Founder to Speak at WHX Dubai 2026

Our co-founder & CEO Dr. Manasi Aichmueller Ratnaparkhe will take the stage at WHX Dubai 2026 to share her journey of scaling a HealthTech startup and...

JPM 2026 Spotlight: The Race for Better Data Is On

JPM Week 2026 highlights that the real bottleneck for AI-driven medicine is no longer algorithms, but the urgency of building diverse, representative datasets for equitable healthcare....

Why AI Accuracy Alone Doesn’t Drive Adoption in Digital Pathology

Even though AI models in digital pathology are reaching expert-level accuracy, clinical adoption still depends far more on trust, workflow integration, and system readiness than performance...

Making AI Feel Instant: How We Built Real-Time AI Feedback

How do you make AI analysis feel instant when it takes 20 seconds to process medical images? At PAICON, we built a system that brings AI-powered...

When Policy Meets DNA: The Politics of Genomic Data

In this ByteSight episode, we speak with Simeón Baker, Executive Director of External Affairs at Genomics England, about how national genomics programs succeed only when policy,...

Meet us at Health Tech Forward

Join us at Health Tech Forward 2025 in Barcelona to meet our team at Booth ST3 and hear our CEO’s keynote on the Remaining84 challenge and...

PAICON’s End-to-End Approach to Software Quality

In our latest article, Nishan Tamang, Software Engineer at PAICON, explains how software quality is not a single milestone but a continuous mindset. From clear requirements...

PAICON Will Exhibit at the 12th Digital Pathology & AI Congress in London

Meet us at the 12th Digital Pathology & AI Congress in London

PAICON and NVIDIA Spotlight Sovereign AI at AI Week

PAICON and NVIDIA jointly highlighted the future of Sovereign AI at AI Week.

Trustworthy Healthcare AI: Turning Technology Into Real Clinical Impact

This article explores how transparency, uncertainty awareness, and workflow-first design turn AI from a technical tool into a reliable component of patient care

AI That Heals: The Real Work Behind Intelligent Medicine

Join this insightful webinar, where our CEO & Co-Founder Dr. Manasi Aichmueller-Ratnaparkhe explores how ethical AI, data diversity, and the Remaining84 initiative are transforming oncology into...

PAICON Presented Cervical Cancer AI Solutions at IPVS 2025 in Bangkok

We presented its cervical cancer AI solutions at IPVS 2025 in Bangkok, showcasing the OncoPath initiative and reinforcing its mission to build equitable, globally inclusive AI...

Hidden Bias in Healthcare AI: Why Better Data Foundations Matter

This article explores how unequal datasets create unsafe or inaccurate AI systems and how PAICON builds stronger, diverse, and multimodal data foundations for trustworthy medical AI....

The Last Mile of AI: Making Digital Pathology Work in Practice

In this ByteSight episode, we speak with Dr. Heather Couture, founder of Pixel Scientia Labs, about why AI models that excel in the lab often fail...

Strengthening Global Collaboration: PAICON Joins Germany-China Delegation

PAICON joined the Germany-China Delegation to advance global cooperation in healthcare innovation. Represented by CEO Dr. Manasi Aichmueller-Ratnaparkhe and Data Management Lead Dr. John K.L. Wong,...

Closing the Last-Mile AI Gap: From Lab-Perfect to Clinic-Ready

AI models that excel in lab environments often underperform in real-world hospitals due to technical variability and demographic bias. This article explores the last-mile AI gap...

PAICON at Neurons and Neckar Conference

At the Neurons and Neckar event in Heidelberg, our CTO and Co-Founder Dr. Christian Aichmueller introduced PaiX, PAICON's global cancer datalake, and showcased SatSight Dx, an...

Standing on the Shoulders of Giants: PAICON in the Cloud

How can a small healthtech startup manage terabytes of medical data, train powerful AI models, and stay fully compliant—without owning a single server? At PAICON, the...

PAICON at the German Indian Innovation Corridor

At the German Indian Innovation Corridor in Berlin, PAICON joined thought leaders shaping the future of global innovation. Our CEO and Co-Founder Dr. Manasi Aichmueller-Ratnaparkhe contributed...

A Test Too Late: When Standard Chemo Becomes Deadly

Each year, over a thousand patients die from preventable chemotherapy toxicity caused by genetic variants like DPYD deficiency. This story of JoEllen Zembruski-Ruple exposes how a...

Technical vs. Biological Diversity: Designing for Generalization

AI in pathology can achieve high accuracy in controlled environments but often struggles to generalize across scanners, stains, and patient populations. This article explores why both...

Out of the Lab, Into the Living Room: The Future of Accessible Genomics

In this episode of ByteSight, Dr. Catalina Lopez-Correa shares how genomics is moving into everyday life and why equity is essential. As both a global leader...

OncoPath: Offline-First Architecture for Cervical Cancer Studies

OncoPath introduces an offline-first architecture designed for cervical cancer studies in low-resource settings. By making each device the primary source of truth, the system ensures no...

PAICON at the European Congress of Pathology 2025 in Vienna

PAICON was proud to be part of the 37th European Congress of Pathology in Vienna, where leading experts gathered to explore the future of pathology and...

PAICON at HGS MathComp Annual Retreat 2025

PAICON was honored to participate in the HGS MathComp Annual Retreat 2025, an event that brought together fellows, alumni, and researchers at the intersection of mathematics,...

From Germany to the UK: PAICON at Cambridge Tech Week

We joined the Cambridge Tech Week 2025, where innovation meets community and ideas move seamlessly between research, industry, and entrepreneurship.

PAICON at the MSI Symposium Heidelberg 2025

Dr. Witali Aswolinskiy, AI Lead at PAICON, delivered a talk at the European Symposium on Tumors with Microsatellite Instability (MSI) - Heidelberg 2025 Edition.

PAICON at WHX Tech 2025: Driving Equity in Cancer Diagnostics

We exhibited at WHX Tech 2025, presenting our vision of transforming cancer care with genetically and technically diverse data combined with robust AI models.

Equity in Clinical Trials: Closing the Participation Gap

Clinical trials are the foundation of progress in cancer care. Yet participation in clinical trials remains unequal.

Remaining84 in Real Life: The Danger of Ignoring Genetic Diversity in Precision Medicine

At Indiana University's Precision Genomics Clinic, a breast cancer patient's standard chemotherapy treatment took a devastating turn. What should have been routine care left her hospitalized...

Patient - Clinician Communication in the Age of AI

AI is transforming healthcare, bringing powerful tools for diagnostics, treatment planning, and patient management. Yet as technology becomes embedded in clinical practice, one constant remains -...

Data Diversity and Social Barriers: Addressing Racial Disparities in Breast Cancer Outcomes

Breast cancer is the most common cancer among women worldwide, but outcomes are not equal across population due to racial and ethnic disparities

Genomic Equity Starts Here: Transforming Global Health Through African Genomics

Prof. Segun Fatumo explains why Africa’s genomic diversity is key to advancing precision medicine and achieving global health equity

PAICON Featured in FOUND - Startup Magazine Heidelberg

PAICON has been featured in FOUND – Startup Magazin Heidelberg, where our mission, innovations, and flagship AI solutions like SatSight DX are highlighted as drivers of...

The Remaining84 in Real Life: A Common Cancer Drug Took Her Life Instead of Saving

A 60-year-old woman’s tragic reaction to a common cancer drug exposes the Remaining84 problem: the 84% of the world’s population underrepresented in genomic data. At PAICON,...

PAICON at Cambridge Tech Week 2025

PAICON is showcasing its AI-powered oncology solutions at Cambridge Tech Week 2025 in UK (15 - 18 September).

Global Collaboration Needed for AI in Oncology

AI in oncology cannot succeed without global collaboration. The Remaining84 problem highlights how most cancer datasets come from just 16% of the world’s population. PAICON is...

Meet Us at WHX Tech 2025, Dubai

PAICON is showcasing its AI-powered oncology solutions at WHX Tech 2025 in Dubai (8 - 10 September). Visit us at Stand S2.B40!

Meet our AI Lead at European Symposium on Tumors with Microsatellite Instability in Heidelberg

PAICON’s AI Lead, Dr. Witali Aswolinskiy, will showcase how uncertainty-aware AI models can enhance MSI detection in colorectal cancer, driving more precise and equitable oncology diagnostics...

PAICON’s Approach to Data Governance for Non-Medical Device AI and AI-enabled IVDs

By developing compliant AI frameworks and showcases, we provide a foundation that helps manufacturers and partners accelerate innovation while maintaining the highest standards of safety and...

Explainable AI in Pathology: Building Trust in Clinical Diagnostics

Explainable AI (XAI) is bridging the gap between powerful cancer diagnostics and clinical trust. By making predictions transparent and interpretable, XAI empowers pathologists and clinicians to...

Meet Us at European Congress of Pathology 2025 in Vienna

PAICON’s AI Lead, Dr. Witali Aswolinskiy, will present his recent research on how AI can improve biomarker prediction and tissue classification, combining speed, accuracy, and interpretability...

PAICON at HGS MathComp Annual Retreat 2025

PAICON’s Bioinformatics Lead, Dr. John KL Wong, will speak at the HGS MathComp Annual Retreat 2025 in Würzburg. His talk will showcase how PAICON applies bioinformatics...

Foundation Models in Computational Pathology: Opportunities & Hurdles

Foundation models are transforming computational pathology with more accurate, adaptable cancer diagnostics. At PAICON, we see them as key to making oncology AI more inclusive, reliable,...

Genomics and the Path to Health Equity

Dr. Manuel Corpas explores how genomics can serve all people, discussing data diversity challenges and solutions for ensuring equitable access to genetic medicine worldwide.

Grounding PAiChat in Reality: Building a Reliable Dataset for Histopathology Assistants

Recent advancements in visual language models have shown promising results even when trained on relatively small publicly available datasets.

The Remaining84 in Real Life: Killed by a Chemotherapy Meant to Save Him

When Dr. Anil Kapoor, a respected urologist and head of transplants at St. Joseph's Healthcare in Hamilton, Ontario, was diagnosed with stage four colon cancer in...

Can AI Learn the Dialect of Histology?

Histology is more than what meets the eye; it's a complex language. Now, artificial intelligence is beginning to understand its syntax.

The Hidden Hero Behind Cancer AI: Clean Data

AI is rapidly becoming a key technology in cancer diagnostics, especially in digital pathology.

Why Black-Box AI Doesn't Work in Cancer Care and What the Future Looks Like Instead

AI is accelerating progress in cancer care, from improving early detection to helping tailor treatments with greater precision. But one major challenge still stands in the...

AI in Healthcare: Between Hype and Hope

Dr. Rohit Thanki discusses the crucial challenges of data authenticity, global inequality in AI readiness, and regulatory fragmentation facing AI implementation in healthcare.

Designing AI-Driven Diagnostics for Low-Resource Settings

In the pursuit of global health equity, artificial intelligence (AI) stands at a transformative crossroads. While AI-powered diagnostics have shown immense promise in high-income healthcare systems,...

Building Health Equity Through Global Partnerships: Insights from Chile

PAICON’s recent visit to Chile highlighted how meaningful international collaboration can drive progress toward health equity. By connecting with Chilean scientists, entrepreneurs, and leaders, Dr. Manasi A-Ratnaparkhe,...

AI-Powered Oncology Trials

A landmark systematic review and meta-analysis confirms what the healthtech world has long anticipated: artificial intelligence (AI) is not just promising but already effective in optimizing...

From Slides to System: Building AI on Solid Data

Dr. Uwe Schalles explores the foundational role of data curation in the development of AI for digital pathology, discussing challenges and realities of sourcing high-quality data....

From Research to Real-World Solutions: PAICON at the Applied Science Meetup

PAICON’s Co-founder and CTO, Dr. Christian Aichmüller, presented at the Applied Science Meetup: Algorithms with Impact, organized by TUM Venture Labs at the TUM Campus Heilbronn.

Deep Learning-Based Zero Watermarking for Medical Data Security

The digitization of healthcare and the rise of AI-based diagnostics have made the secure handling of medical data a fundamental requirement; not just for compliance, but...

Championing Equity in AI: PAICON CEO Speaks at Science Sparks Startups

At the Science Sparks Startups event, our co-founder and CEO, Dr. Manasi A. Ratnaparkhe, shared PAICON’s pioneering vision for building inclusive artificial intelligence solutions for cancer...

PAICON Featured in Rhein-Neckar-Zeitung

We’re thrilled to share that Rhein-Neckar-Zeitung (RNZ) recently interviewed our founders, Dr. Christian Aichmüller and Dr. Manasi A-Ratnaparkhe, in a deep dive into PAICON’s mission to transform cancer diagnostics and therapeutics...

PAICON Launches Remaining84.com: A Campaign for Equity in Cancer AI

We are proud to announce the official launch of Remaining84.com, the digital home of our global awareness campaign to address the glaring gap in cancer data equity....

Unlocking Diversity in Genomics at the Spanish Genomic Conference

PAICON had the honor of participating in the Spanish Genomic Conference in Madrid, where thought leaders, researchers, and innovators came together to explore the future of...

Introducing PAiChat: Enhancing Pathologists’ Workflow with AI-Driven Multimodal Support

The global shortage of qualified pathologists has become a pressing issue, significantly impacting healthcare systems worldwide [1]. Efficient use of pathologists’ time and expertise is important....

From Code to Clinic: How AI is Shaping the Future of Cancer Target Discovery

In recent years, AI has evolved from an academic curiosity to a clinical enabler in oncology. With the digitization of medical imaging, electronic health records, and...

Toward a Diagnostic Co-Pilot: Can AI Understand Medical Images and Language?

In recent years, AI has made remarkable progress across medicine. From reading X-rays to predicting patient outcomes, AI is becoming a trusted partner in clinical settings....

ByteSight: PAICON's Expert Podcast on the Future of Digital Health

PAICON announces the launch of ByteSight, a monthly podcast bringing together leading voices in digital health to explore the innovations, challenges, and ideas shaping the future...

Why Diversity in Cancer Genomics Matters: BRCA Mutations in Latina Women

The rise of precision oncology has underscored the importance of understanding genetic variation in cancer risk and treatment. However, this progress is unevenly distributed. Hispanic/Latina women,...

AI in Cervical Cancer Screening and Digital Colposcopy

Cervical Cancer is caused by the human papillomavirus (HPV) and is one of the deadliest cancer types for women in low to middle income countries (LMIC),...

Inclusive AI Starts Locally, Grows Globally

In the age of AI-powered healthcare, data is not just a resource, it’s the foundation of innovation. Yet the promise of artificial intelligence in medicine can...

PAICON at DMEA 2025: A Win, A Movement, A Mission

PAICON participated in DMEA 2025 in Berlin, one of Europe’s leading digital health events, showcasing our commitment to transforming real-world, genetically and technologically diverse cancer data...

PAICON at the Graduate School Life Science Engineering Retreat

Our Data Management Lead, Dr. John Wong, recently participated in the Graduate School Life Science Engineering Retreat held in the breathtaking surroundings of Kleinwalsertal, Austria.

AI Beyond the Microscope: Multimodal Data in Cancer Care

Cancer is a profoundly complex and heterogeneous disease, evolving through layers of genetic, molecular, cellular, and systemic changes. Capturing this complexity demands diagnostic approaches that extend...

AI Can’t Wait: Tackling Cancer Inequity in Low-HDI Countries

The global cancer burden is rising at an unprecedented pace. According to the latest data from the Global Cancer Observatory, new cancer cases worldwide are projected...

Meet us at DMEA 2025

Join PAICON at DMEA 2025 in Berlin—celebrating our Nova Award finalist nomination and showcasing inclusive AI tools for cancer diagnostics.

Multimodal Integration of Transcriptomics and Histopathology: Addressing Population Variation in AI-Based Cancer Diagnostics

In the era of precision medicine, the convergence of genomics and histopathology represents a transformative opportunity for oncology diagnostics.

PAICON Achieves ISO 13485 Certification from TÜV SÜD

We are proud to announce that PAICON GmbH has been officially certified by TÜV SÜD in accordance with ISO 13485:2016, a globally recognized standard for quality...

What Makes a Good Cancer Dataset for AI? Key Features and Pitfalls

The rapid growth of artificial intelligence in oncology brings with it a pressing requirement: access to high-quality, well-structured data. While algorithm development often gets the spotlight,...

“Beyond Funding”: Our CEO at Female Founders Pitch Night

On March 14th, 2025, our CEO & Co-Founder, Dr. Manasi A-Ratnaparkhe, delivered an inspiring keynote. Her talk, titled Beyond Funding – The Art of Building an Agile...

Synthetic Data in Oncology: Can It Replace Real Slides for Training?

As artificial intelligence (AI) continues to advance the field of oncology, the need for large, diverse, and high-quality data has never been more pressing.

Coming Soon: ByteSight – Insights from Every Byte

PAICON is proud to launch ByteSight, a new expert talk series designed to spark discussions on the future of digital health and AI-driven cancer diagnostics. ByteSight...

The Blind Spot: What If AI Doesn’t Know You Exist

Artificial intelligence (AI) is reshaping cancer research by improving early detection, optimizing treatment strategies, and driving advancements in precision medicine. Yet, beneath its promise lies a...

Complexity Landscape of Genomics and Transcriptomics for Precision Medicine

Ongoing improvements in sequencing technology, big data analytics and AI are radically transforming our ability to understand the molecular basis of disease and expanding our diagnostic...

PAICON on the Spillover Podcast

Dr. Christian Aichmüller joins the Spillover Podcast to discuss PAICON’s vision for AI in cancer diagnostics and digital healthcare.

Real-Life Cases of AI Bias in Cancer Diagnostics

Artificial intelligence (AI) is revolutionizing healthcare, offering powerful tools for cancer detection and diagnosis. However, the growing reliance on AI models brings an urgent concern:

Understanding Bias in AI-Driven Cancer Diagnostics

AI in oncology enables early cancer detection, improves diagnostics, and personalizes treatment plans. However, these advancements are only as reliable as the data they are built...

United by Unique: Innovating Today for a Cancer-Free Tomorrow

Cancer remains one of the leading causes of death worldwide, claiming nearly 10 million lives each year, according to the World Health Organization (WHO). It affects...

AI in Cancer Care: Challenges and Path to Equity

Artificial Intelligence (AI) is changing the way cancer is diagnosed and treated, offering new possibilities for early detection, accurate diagnoses, and personalized care.

How AI and Big Data Are Changing Breast Cancer Treatment

Breast cancer affects every patient differently. Traditional treatments use a general approach, but with big data, doctors can now provide more personalized care.

PAICON – IXORA Symposium: An Evening of Collaboration and Innovation

On January 19th, 2025, PAICON and IXORA Digital Health hosted an exclusive symposium in Pune, India, bringing together doctors, collaborators, and experts in cancer diagnostics.

Patient Similarity in Cancer Diagnostics

The integration of big data and machine learning into oncology is shaping the future of cancer care. By analyzing extensive datasets, these technologies offer a new...

Is AI the Future of Patient Education? Lessons from ChatGPT and Colorectal Cancer

The transformative potential of artificial intelligence (AI) in healthcare is undeniable. With its ability to process vast amounts of information and provide instant responses, AI offers...

AI Revolutionizing Ovarian Cancer Diagnosis

A study titled “International Multicenter Validation of AI-Driven Ultrasound Detection of Ovarian Cancer”, recently published in Nature Medicine, explores the role of artificial intelligence (AI)

Unlocking the Potential of Data-Driven AI in Oncology: PAICON’s Vision and Global Relevance

In the evolving field of oncology, the integration of artificial intelligence (AI) has unlocked transformative potential for diagnostics, research, and treatment pathways.

PAICON and Morphle Labs Announce Partnership to Revolutionize Cancer Diagnostics with Integrated AI Solutions

PAICON, a global leader in cancer diagnostic AI, and Morphle Labs, an innovator in digital pathology hardware and software, are excited to announce a groundbreaking partnership.

PAICON at Research and Development Career Day

PAICON’s CEO joins the DKFZ R&D Career Day to share insights into innovation, data diversity, and the future of cancer diagnostics.

Resilience: The Driving Force Behind PAICON’s Success

Last week, at the DKFZ Career Day 2024, PAICON’s co-founder and CEO Dr. Manasi Aichmueller-Ratnaparkhe shared an inspiring message with PhD, postdoc, and master’s students about the...

PAICON Wins Heidelberg Start-up Award 2024

PWe’re thrilled to announce that PAICON has been awarded the prestigious Heidelberg Start-up Award 2024 in the Innovation category!

Artefact-Aware-AI for Reliable Histopathology: Overcome Imaging Artefacts

The digitalisation of histopathology slides is opening innovative opportunities in pathology, particularly by integrating artificial intelligence into routine histopathological diagnoses.

Germany’s National Cancer Plan: A New Phase for Better Care

The German Federal Ministry of Health recently announced the next phase of the National Cancer Plan, focusing on improving cancer prevention, early detection, treatment, and post-treatment...

The EU’s Perspective on AI in Healthcare: Applications, Risks, and Ethical Challenges

Artificial intelligence (AI) is transforming industries and society, offering unprecedented opportunities for innovation and efficiency.

Balancing Innovation with Privacy: GDPR Compliance in Medical Data

The donation of data has become essential to the advancement of medical research and the development of medical products.

Germany’s New Medical Research Law

Germany’s Bundesrat has passed the Medical Research Law, a landmark initiative to strengthen the nation as a leader in pharmaceutical and medical device research.

PAICON’s AI Solution for Breast Cancer Diagnostics

Breast cancer remains one of the leading causes of cancer-related deaths globally, affecting millions of women each year.

LEOPARD Challenge 2024 – Celebrating PAICON’s Success

In the ever-evolving field of AI-driven healthcare, global competitions such as the LEOPARD Challenge play a pivotal role in advancing research and enhancing personalized diagnostics.

AI-Driven Analysis of Rare Genetic Variants

In a significant leap for genetic research, a collaborative team from the German Cancer Research Center (DKFZ), EMBL, and the Technical University of Munich has introduced...

Advancing Breast Cancer Screening with AI Technology

In a review published by the European Journal of Radiology, researchers explored the potential of Artificial Intelligence (AI) to revolutionize breast cancer screening through advancements in...

Global Breast Cancer Burden

Breast cancer remains the most commonly diagnosed cancer worldwide, posing significant public health challenges.

Advancing Diagnostics with AI and Digital Pathology

In today’s rapidly evolving cancer research, the integration of Digital Pathology and Artificial Intelligence (AI) plays a critical role in transforming diagnostics.

WHO Report Explores the Benefits and Challenges of AI in Pharmaceutical Development

The WHO report on AI in pharmaceutical development emphasizes both the immense potential and the complex challenges AI introduces to the field.

New Study: AI Reveals Hidden Subgroup in Endometrial Cancer

A new study has demonstrated the power of artificial intelligence (AI) in enhancing our understanding of endometrial cancer (EC), particularly within the largest subtype known as...

PAICON at the 9th Healthcare Symposium: From Data to Diagnostics

PAICON recently took part in the 9th Healthcare Symposium in Berlin, where our Managing Director Danny Quick delivered a compelling presentation on the critical role of...

Our Managing Director Presents at the 9th Healthcare Symposium

Danny Quick, Managing Director at PAICON, presents on AI in diagnostics at the 9th Healthcare Symposium organized by Arvato Systems.

Understanding the Impact of Unbiased Data for AI in Healthcare

In today’s world of data-driven medicine, the quality of information is everything. Unbiased data forms the foundation of fair, effective, and inclusive healthcare AI.

PAICON Summer Party

Our recent summer party was a wonderful celebration of the values that define our company.

PAICON at MIDL2024: Advancing AI in Medical Imaging

The MIDL2024 conference in Paris was exceptionally well-organized, focusing on groundbreaking advancements in medical imaging.

PAICON Company Retreat Recap

Our recent company retreat at Strotzbüscher Mühle was a valuable experience for our team.

PAICON SatSight DX for Rapid MSI Detection in Colorectal Cancer

Microsatellite instability (MSI) is a critical biomarker in colorectal cancer (CRC), influencing diagnosis, prognosis, and treatment decisions. Traditional MSI detection methods, such as immunohistochemistry (IHC) and...

PAICON Shines at Health.Tech 2024 with AI Solutions

Attending the Health.Tech Conference in Munich was a major milestone for PAICON.

Meet PAICON at Health.Tech 2024!

PAICON will showcase its AI/ML-powered cancer data solutions at Health.Tech 2024, Europe's top digital health conference.

From Normal to Abnormal: Transforming Medical Images with Diffusion Models for Dataset Balancing

Paulikat M, Nauschütte L, Kalteis MS, Aswolinskiy W, Schneider A, Bussmann H, Aichmüller C, von Knebel Doeberitz M

Using diffusion models to synthesise high-grade lesion features inside normal cervical images, balancing a Cambodian screening dataset where such cases are scarce and improving diagnostic performance by 5%.

PAICON Exhibited at DMEA 2024 in Berlin

Participating in DMEA Connecting Digital Health provided an exceptional opportunity for PAICON to engage with like-minded startups and companies dedicated to improving healthcare through innovative data...

Meet PAICON at DMEA 2024!

PAICON will participate as an exhibitor at DMEA 2024, showcasing its AI/ML-powered cancer data lake at Europe’s leading digital health event.

Wrap-up: Keynote Lecture STMM Industry and Innovation Days

Our co-founder and managing director, Dr. Manasi Aichmueller-Ratnaparkhe, attended the STMM Industry and Innovation Days at the Heidelberg University as a keynote speaker on 8 March...

Keynote Lecture at the STMM Industry and Innovation Days

Dr. Manasi Aichmüller-Ratnaparkhe delivers a keynote at STMM Industry and Innovation Days 2024 on fearless innovation and tackling AI bias in medicine.

PAICON’s Partnership with UKHD and DKFZ

In an ever-evolving healthcare landscape, continuous collaboration is key to driving meaningful advancements.

EU AI Act Enacted: New Rules for AI Risk and Oversight

The EU AI Act, introduced in June 2023, is a significant milestone in regulating artificial intelligence within the European Union.

PAICON Exhibited at NLS 2023 in Copenhagen

PAICON stepped onto the stage at the Nordic Life Science Days on 29–30 November 2023, which is one of the most prominent events in the life...

Meet PAICON at NLS 2023!

PAICON will exhibit at NLS Days 2023 in Copenhagen, showcasing data-driven solutions in healthcare and diagnostics.

Data Donation Can Save Lives

Becoming a hero with blood or organ donation sounds familiar? What about becoming a hero with data donation? Is donating medical data or records as easy...

How Can Big Data in Medical Research Eliminate Health Disparities?

Health disparities refer to potentially avoidable systematic differences in health between disadvantaged and advantaged social groups, which are mainly determined either socially and/or economically.

Insights on Keynote Lecture at EuroSTEMPeers 2023

Dr. Manasi Aichmüller-Ratnaparkhe, co-founder of PAICON, was a featured speaker at EuroSTEMPeers on 3 June 2023, which is an influential conference hosted by the European chapter...

Talk about Digital Health and Data Science at EuroSTEMPeers 2023

Join us at EuroSTEMPeers where our co-founder, Dr. Manasi Aichmüller-Ratnaparkhe, will discuss the intersections of Digital Health and Data Science.

Bertelsmann Investments Becomes Shareholder in Digital Health Start-up Alongside German Cancer Research Center

tersloh / Heidelberg, November 17, 2022 – Bertelsmann Investments has acquired shares in PAICON, a Heidelberg-based digital health start-up. Other fellow shareholders include the German Cancer...

Data Privacy Compliance in Healthcare

The average person does not have a clear knowledge of what forms of health data are protected by law. Gaps in knowledge, as well as a...

US CLOUD Act vs. EU GDPR: What you need to know

The U.S. Clarifying Lawful Overseas Use of Data Act (CLOUD Act) was passed in 2018, mooting the then pending U.S. Supreme Court case – United States....